Day: August 6, 2026

Enrolling patients in clinical trials has long been one of the steepest operational hurdles in medical innovation. For years, researchers have debated whether financial compensation serves as a necessary driver for recruitment or an unethical bribe that skews participant motivation. A recent study published in JAMA Internal Medicine provides crucial clarity on this long-standing dilemma. The data reveals … Read more

When senior FDA leadership published “America Must Address Early Clinical Development” on the official FDA Voices blog, industry stakeholders immediately take notice. However, beneath the bold rhetoric lies a familiar structural tension that has plagued recent regulatory communications: the conflation of executive vision with enforceable policy. Outlining an ambitious “Expedited IND Pilot” utilizing Qualified Research Institutions (QRIs) and rolling submissions, the agency framed the … Read more